FIGHTING AGAINST CHILD MORTALITY DUE TO TUBERCULOSIS

Date de publication
Tue, 03/24/2020 - 09:00
Catégorie

Along with drug-resistance in bacteria, non-detection among about 40% of those living with the disease is a major challenge in eliminating tuberculosis in the world. The 5% Initiative funds operational research projects that evaluate innovative strategies for improving screening and treatment.

Zone centrale
Titre du bloc
DIAGNOSIS AND TREATMENT : TWO KEY ISSUES
Contenu du bloc

 

Every year, about 10 million people contract tuberculosis and 1.7 million die of it, according to WHO estimates. In 2016, only 6.3 million cases were detected and correctly registered in national and supranational monitoring systems. Considerable efforts are still required to make treatment and medical and social services available to all those affected by tuberculosis, to thereby eradicate the pandemic by 2035.

 

Titre du bloc
TESTING A NEW PEDIATRIC DIAGNOSIS PROTOCOL
Contenu du bloc

 

The operational research project TB-Speed aims to reduce infant mortality rates due to tuberculosis by strengthening national programs and evaluating innovative diagnostic methods.

Implemented by an international consortium coordinated by the University of Bordeaux and co-funded by Unitaid, the TB-Speed project works in six countries with high infection rates: Côte d’Ivoire, Cameroon, Cambodia, Mozambique, Uganda and Zambia. It seeks to evaluate the impact of systematic early detection on morbidity and mortality rates in children with severe pneumonia. Majority funding comes from Unitaid. The 5% Initiative is co-funding the TB-Speed Pneumonia component being carried out in Cambodia, Cameroon, Côte d’Ivoire and Mozambique.

 

TB-Speed
Responsive (recommandé)
Titre du bloc
AN INNOVATIVE DIAGNOSIS TECHNIQUE
Contenu du bloc

 

Based on WHO standards, the study will be carried out on 3,800 children in 15 partner hospitals using portable equipment for aspirational nasopharyngeal sampling and the GeneXpert Edge platform. This compact battery-powered platform will make it possible to use the Xpert MTB/RIF Ultra molecular tuberculosis diagnosis test on stool and nasopharyngeal samples, easier to perform than the usual sampling methods.

The project’s first year was dedicated to writing a research protocol and ensuring its validation by ethics committees, including WHO’s, as well as to recruiting and training field teams. The study was officially launched in early 2019.

>> Find the TB-Speed project on the dedicated website.

 

x

Receive "The Initiative's news"

Subscribe to our newsletter "L'Initiative's news". If you fill in your e-mail address, you accept that Expertise France will send you its news. We will treat your e-mail address in accordance with our personal data management policy. We invite you to consult it in order to know your rights.